MCC
AZN icon

Malaga Cove Capital’s AstraZeneca AZN Stock Holding History

Malaga Cove Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.29M Buy
6,791
+163
+2% +$30.7K 0.41% 67
2026
Q1 		$1.31M Sell
6,628
-365
-5% -$70.4K 0.47% 64
2025
Q4 		$1.29M Sell
6,993
-309
-4% -$54.2K 0.45% 68
2025
Q3 		$1.12M Buy
7,302
+295
+4% +$44.6K 0.41% 76
2025
Q2 		$979K Sell
7,007
-75
-1% -$10.5K 0.38% 77
2025
Q1 		$1.04M Sell
7,082
-229
-3% -$33.1K 0.45% 63
2024
Q4 		$958K Sell
7,311
-12
-0.2% -$1.68K 0.38% 65
2024
Q3 		$1.14M Sell
7,323
-1,252
-15% -$202K 0.46% 57
2024
Q2 		$1.34M Sell
8,575
-90
-1% -$13.5K 0.54% 53
2024
Q1 		$1.17M Buy
8,665
+1,746
+25% +$231K 0.48% 59
2023
Q4 		$932K Sell
6,919
-1,822
-21% -$237K 0.39% 72
2023
Q3 		$1.18M Hold
8,741
– – 0.55% 54
2023
Q2 		$1.25M Hold
8,741
– – 0.58% 57
2023
Q1 		$1.21M Buy
8,741
+19
+0.2% +$2.56K 0.6% 57
2022
Q4 		$1.18M Hold
8,722
– – 0.65% 51
2022
Q3 		$957K Buy
8,722
+1,835
+27% +$233K 0.55% 59
2022
Q2 		$908K Hold
6,887
– – 0.51% 67
2022
Q1 		$914K Hold
6,887
– – 0.42% 81
2021
Q4 		$802K Hold
6,887
– – 0.31% 100
2021
Q3 		$827K Hold
6,887
– – 0.34% 100
2021
Q2 		$825K Hold
6,887
– – 0.35% 100
2021
Q1 		$687K Sell
6,887
-1
-0% -$101 0.29% 112
2020
Q4 		$698K Buy
6,888
+2,621
+61% +$278K 0.33% 105
2020
Q3 		$468K Buy
+4,267
New +$475K 0.27% 116

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Malaga Cove Capital's AZN Position: Q2 2026 in Review

Malaga Cove Capital increased its AstraZeneca (AZN) stake by 2.5% in Q2 2026, buying an estimated $30.7K and bringing the position to 6,791 shares worth $1.29M. The position accounts for 0.41% of the portfolio, ranked #67.

Malaga Cove Capital first reported a position in AZN in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.34M in Q2 2024. 1,507 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Malaga Cove Capital held 6,791 shares of AstraZeneca worth $1.29M as of Q2 2026.
  • Malaga Cove Capital bought 163 AstraZeneca shares in Q2 2026, an estimated $30.7K.
  • AstraZeneca made up 0.41% of Malaga Cove Capital's portfolio in Q2 2026, its #67 holding.
  • Malaga Cove Capital first reported a position in AstraZeneca in Q3 2020 and has held it in 24 quarters since.
  • Malaga Cove Capital's AstraZeneca position peaked at $1.34M in Q2 2024.
  • 1,507 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Malaga Cove Capital's 13F filing for Q2 2026, filed 24 Jul 2026.